Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP demonstration project for men who have sex with men and transgender people at high risk of HIV in Brazil, Mexico, and Peru
RBR-4x3cnpRecruiting
- Sponsor
- Evandro Chagas National Institute of Infectology
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of emtricitabine and tenofovir disoproxil fumarate in human immunodeficiency virus infection (HIV), sponsored by Evandro Chagas National Institute of Infectology. Started Feb 2018; status: recruiting.
02
Drugs
emtricitabinetenofovir disoproxil fumarate
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on RBR-4x3cnp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4x3cnp.